Efficiency of Botulinum Toxin Injection for Spastic Equinovarus Foot in Post Stroke Hemiparetic Patients

• Status: Completed
• Trial end date: 2010-11-17
• Target enrollment: 0
• Participant gender: All

Summary

Botulinum toxin is the main treatment for focal spasticity but the effects of botulinum toxin injections with respect to limitations of gait activities are still discussed. The aim of this study is to to investigate the effects of intramuscular Botulinum toxin type A injections on quantitative gait parameters (gait speed, step length and width, single support time) and posture, in hemiparetic post stroke patients with lower limb spasticity.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assistance Publique Hopitaux De Marseille
• Treatments: Botulinum Toxins

Criteria

Inclusion Criteria:

• Chronic stroke hemiplegic patients presenting lower limb spasticity

• A minimum 12-month interval since stroke,

• Lower limb spasticity with a Modified Ashworth Scale greater than or equal to 2 on the triceps surae

• Minimum 6-month interval since a previous BTx-A injection

• To be older than 18 years.

• Patients must have an indication of treatment with Botulinum toxin, determined by a Physical and Rehabilitation Medicine specialist, based on clinical examination and gait analysis

Exclusion Criteria:

• Contraindication to the use of botulinum toxin: Myastenia, Lambert Eaton syndrome, ALS, pregnancy, breast-feeding, treatment with aminoglycoside, cyclosporine, previous hypersensitivity to botulinum toxin

• Contraindication to intramuscular injections

• Patients unable to give consent